Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29684 | 149 | 41.8 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
971 | 10192 | PHOTODYNAMIC THERAPY//PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY//HYPERICIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHOTOCHEMICAL INTERNALIZATION | Author keyword | 43 | 62% | 30% | 45 |
2 | PHOTOCHEMICAL INTERNALISATION | Author keyword | 24 | 91% | 7% | 10 |
3 | CANC STEM CELL INNOVAT SFI CAST | Address | 5 | 60% | 4% | 6 |
4 | PHOTOCHEMICAL INTERNALIZATION PCI | Author keyword | 2 | 43% | 2% | 3 |
5 | ALPCS2A | Author keyword | 1 | 50% | 1% | 2 |
6 | CLOSTRIDIUM PERFRINGENS PROTOTOXIN | Author keyword | 1 | 100% | 1% | 2 |
7 | HER2 NEU ERBB2 | Author keyword | 1 | 100% | 1% | 2 |
8 | RHEUMATOID ARTHRIT SURG | Address | 1 | 100% | 1% | 2 |
9 | TARGETED OPENING | Author keyword | 1 | 100% | 1% | 2 |
10 | GELONIN | Author keyword | 1 | 11% | 5% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHOTOCHEMICAL INTERNALIZATION | 43 | 62% | 30% | 45 | Search PHOTOCHEMICAL+INTERNALIZATION | Search PHOTOCHEMICAL+INTERNALIZATION |
2 | PHOTOCHEMICAL INTERNALISATION | 24 | 91% | 7% | 10 | Search PHOTOCHEMICAL+INTERNALISATION | Search PHOTOCHEMICAL+INTERNALISATION |
3 | PHOTOCHEMICAL INTERNALIZATION PCI | 2 | 43% | 2% | 3 | Search PHOTOCHEMICAL+INTERNALIZATION+PCI | Search PHOTOCHEMICAL+INTERNALIZATION+PCI |
4 | ALPCS2A | 1 | 50% | 1% | 2 | Search ALPCS2A | Search ALPCS2A |
5 | CLOSTRIDIUM PERFRINGENS PROTOTOXIN | 1 | 100% | 1% | 2 | Search CLOSTRIDIUM+PERFRINGENS+PROTOTOXIN | Search CLOSTRIDIUM+PERFRINGENS+PROTOTOXIN |
6 | HER2 NEU ERBB2 | 1 | 100% | 1% | 2 | Search HER2+NEU+ERBB2 | Search HER2+NEU+ERBB2 |
7 | TARGETED OPENING | 1 | 100% | 1% | 2 | Search TARGETED+OPENING | Search TARGETED+OPENING |
8 | GELONIN | 1 | 11% | 5% | 7 | Search GELONIN | Search GELONIN |
9 | PHOTOMORPHOLINO | 1 | 50% | 1% | 1 | Search PHOTOMORPHOLINO | Search PHOTOMORPHOLINO |
10 | SUCROSOMES | 1 | 50% | 1% | 1 | Search SUCROSOMES | Search SUCROSOMES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOTOXIN MOC31 GELONIN | 13 | 71% | 7% | 10 |
2 | PHOTOCHEMICAL INTERNALIZATION | 9 | 25% | 20% | 30 |
3 | INTERFERING RNA MOLECULES | 8 | 100% | 3% | 5 |
4 | DIRECTED GENE DELIVERY | 3 | 57% | 3% | 4 |
5 | TPCS2A | 1 | 100% | 1% | 2 |
6 | CONJUGATE GENERATION 3 | 1 | 50% | 1% | 1 |
7 | FLUORESCENCE EMISSIONS | 1 | 50% | 1% | 1 |
8 | MESO TETRAHYDROXYPHENYL CHLORIN | 1 | 50% | 1% | 1 |
9 | SULFONATED MESO TETRAPHENYLPORPHINES | 1 | 13% | 3% | 5 |
10 | 5 FLUOROURACIL SENSITIVITY | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Delivery of siRNA to the Target Cell Cytoplasm: Photochemical Internalization Facilitates Endosomal Escape and Improves Silencing Efficiency, In Vitro and In Vivo | 2008 | 21 | 59 | 24% |
Photochemical internalization: A new tool for drug delivery | 2007 | 42 | 79 | 38% |
Photochemical internalization (PCI) in cancer therapy: From bench towards bedside medicine | 2009 | 32 | 71 | 25% |
Photochemical internalisation in drug and gene delivery | 2004 | 112 | 75 | 15% |
Photochemical Internalization: A New Tool for Gene and Oligonucleotide Delivery | 2010 | 4 | 115 | 40% |
Photoinduced RNA Interference | 2012 | 10 | 56 | 16% |
Light-Induced Gene Expression Using Messenger RNA Molecules | 2010 | 3 | 27 | 30% |
Photochemical internalisation: A novel drug delivery system | 2002 | 39 | 49 | 18% |
Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review | 2011 | 24 | 76 | 8% |
Supramolecular nanocarriers integrated with dendrimers encapsulating photosensitizers for effective photodynamic therapy and photochemical gene delivery | 2007 | 37 | 49 | 12% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC STEM CELL INNOVAT SFI CAST | 5 | 60% | 4.0% | 6 |
2 | RHEUMATOID ARTHRIT SURG | 1 | 100% | 1.3% | 2 |
3 | HLTH PHYS DIAGNOST SCI | 1 | 15% | 3.4% | 5 |
4 | CONFOCAL MICROSCOPY CORE IL BIOCHEM | 1 | 50% | 0.7% | 1 |
5 | CORE PROGRAM EVOLUT SCI TECHNOL | 1 | 50% | 0.7% | 1 |
6 | GRGN | 1 | 50% | 0.7% | 1 |
7 | UNITE CHIRURG CERV IALE | 1 | 50% | 0.7% | 1 |
8 | UNITE CHIRURG CERVICO IALE | 1 | 50% | 0.7% | 1 |
9 | IMMUNOPHARMACOL TARGETED THER Y | 1 | 16% | 2.0% | 3 |
10 | ARCT GEOPHYS | 0 | 33% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000185897 | PHOTODYNAMIC THERAPY//PHOTOFRIN//FOSCAN |
2 | 0.0000117531 | GENE DELIVERY//POLYETHYLENIMINE//POLYPLEX |
3 | 0.0000088370 | ORAL BIOL MAXILLO IAL BIOL//STATE BIOBASED FIBER MANU TURE TECHNOL//BIOMOL CIBLES CELLULAI TUMORALES |
4 | 0.0000069217 | MRNA DELIVERY//MRNA TRANSFECTION//RIBOL |
5 | 0.0000067028 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |
6 | 0.0000062866 | LOW DENSITY LIPOPROTEIN LDL RECEPTORS//ATHEROGENIC MICE//BIOCHEM BIOPHYS S |
7 | 0.0000059452 | RIBOSOME INACTIVATING PROTEINS//TRICHOSANTHIN//RICIN |
8 | 0.0000054037 | POLYMERIC MICELLES//POLYMERIC MICELLE//PLURONIC MICELLES |
9 | 0.0000042416 | PHOTOTHERMAL THERAPY//GOLD NANOSHELLS//PHOTOTHERMAL THERAPY PTT |
10 | 0.0000041656 | SULSA//PLASMONIC NANOBUBBLE//BIOMED INFORMAT SCI |